Cargando…

Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a prevalent and complex cardiovascular condition. Despite being strongly associated with genetic alterations, wide variation of disease penetrance, expressivity and hallmarks of progression complicate treatment. We aimed to characterize different huma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhagwan, Jamie R., Mosqueira, Diogo, Chairez-Cantu, Karolina, Mannhardt, Ingra, Bodbin, Sara E., Bakar, Mine, Smith, James G.W., Denning, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487780/ https://www.ncbi.nlm.nih.gov/pubmed/32531470 http://dx.doi.org/10.1016/j.yjmcc.2020.06.003

Ejemplares similares

Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
por: Smith, James G.W., et al.
Publicado: (2018)

Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy
por: Kargaran, Parisa K., et al.
Publicado: (2020)

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
por: Mosqueira, Diogo, et al.
Publicado: (2018)

High-Throughput Phenotyping Toolkit for Characterizing Cellular Models of Hypertrophic Cardiomyopathy In Vitro
por: Mosqueira, Diogo, et al.
Publicado: (2019)

Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
por: Bodbin, Sara E., et al.
Publicado: (2020)

Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the AAVS1 locus as not an entirely safe harbour
por: Bhagwan, Jamie R., et al.
Publicado: (2020)

Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency
por: Saleem, Umber, et al.
Publicado: (2020)

Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells
por: Kondrashov, Alexander, et al.
Publicado: (2018)

Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo
por: James, Victoria, et al.
Publicado: (2021)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format
por: Mannhardt, Ingra, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
por: Waring, Adam, et al.
Publicado: (2021)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Intra-Ramanome Correlation Analysis Unveils Metabolite Conversion Network from an Isogenic Population of Cells
por: He, Yuehui, et al.
Publicado: (2021)

A New 4D Trajectory-Based Approach Unveils Abnormal LV Revolution Dynamics in Hypertrophic Cardiomyopathy
por: Madeo, Andrea, et al.
Publicado: (2015)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

Thromboembolism in Patients with Hypertrophic Cardiomyopathy
por: Liu, Lu, et al.
Publicado: (2021)

The natural history of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy with a Twist
por: Francis, W., et al.
Publicado: (2021)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Editing the trajectory of hypertrophic cardiomyopathy
por: Sweat, Mason E., et al.
Publicado: (2023)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ilk41ht7v81cjn9pv0nsvcgta